Key Highlights
- Adagio Medical Holdings (NASDAQ:ADGM) fell 29.93% a day after announcing a 1-for-30 reverse split effective November 6, 2026, while CL Workshop fell 26.49% before an ADS ratio change equal to 1-for-80.
- NewGenIvf Group Limited (NASDAQ:NIVF) fell 26.05% to USD 0.5121 after a 1-for-8 reverse split took effect on October 23, 2026, with published coverage counting four splits in 2026.
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) rose 20.26% after receiving a Nasdaq minimum bid price notice, giving it until May 3, 2027 to regain compliance.
- Ping An Biomedical Co., Ltd. (NASDAQ:PASW) fell 41.98% after a USD 2.3 million Patent deal, with a 1-for-40 reverse split announced October 21, 2026 according to published coverage.
Ping An Biomedical Co., Ltd. (NASDAQ:PASW): A Split Announced Alongside a Pivot
The largest decline in this group, 41.98% to USD 1.70 in trading on November 5, 2026, per published market data, came at Ping An Biomedical Co., Ltd. (NASDAQ:PASW). Published coverage of late October 2026 reports a 1-for-40 reverse split announced on October 21 and a Nasdaq bid price extension, though both appear only in headlines of that coverage and not in primary text reviewed. A reverse split consolidates every 40 shares into one and raises the quoted price without changing company value, and it is the usual route to restore the USD 1.00 minimum bid. The stock also fell after a November 4, 2026 announcement of a definitive agreement to buy three tumor cell patents from Future Biotechnology Group Co., Limited for USD 2.3 million, with no stated payment form and closing pending. The company, a Cayman Islands Holding Company with an apparel Supply chain business, plans a shelf of up to USD 300 million, and one Shareholder holds about 91.56% of voting power. At a Market Value near USD 5 million, quoted moves can reverse.
CL Workshop Group Limited (NASDAQ:NWGL): An ADS Ratio Change Doing the Work of a Reverse Split
At CL Workshop Group Limited (NASDAQ:NWGL), the ADS fell 26.49% to about USD 0.0408 on 11.68 million units, a quote that predates the change. On November 4, 2026 the company said each American depositary share will represent 640 Class A ordinary shares instead of 8, effective November 6, 2026, subject to Nasdaq confirmation, under a new CUSIP of 63903R205. The company said it has the same effect as a one-for-80 reverse split for ADS holders. Mechanically, the depositary exchanges 80 old ADSs for one new one, so the per-ADS price rises about 80 times while the economic stake stays the same. The announcement gave no reason, but it follows a Nasdaq bid price deficiency notice disclosed in May 2026. Published coverage indicates the first compliance window ended on November 2, 2026, and whether a further period was granted has not been confirmed. After the change the bid must hold at USD 1.00 or higher for 10 consecutive Business days under the general rule. With a market value near USD 3.14 million, Liquidity can thin further.
NewGenIvf Group Limited (NASDAQ:NIVF): Four Splits in 2026 and a Slide That Continues
The 26.05% decline at NewGenIvf Group Limited (NASDAQ:NIVF), to USD 0.5121 on only about 86,140 shares, follows a 1-for-8 reverse split of Class A ordinary shares effective Friday, October 23, 2026, per a Nasdaq corporate actions alert assigning CUSIP G0544E162. An earlier 1-for-3 split took effect on January 26, 2026, and published coverage counts four splits this year. Published coverage put the November 4 close near USD 0.69, so the fall extends a slide from that level. A reverse split raises the quoted price by the same Factor without changing market value, but repeated issuance can restart the cycle. Published coverage, not a filing read here, describes a September 29, 2026 offering of roughly 17.86 million shares or pre-funded warrants at USD 0.07, for about USD 1.25 million, and that detail is unconfirmed. Market value figures conflict across pages, near USD 633,000 in one, so the size of the company is uncertain, and no Nasdaq deadline was verified. Quoted moves in a name this small can reverse.
Adagio Medical Holdings (NASDAQ:ADGM): Split Effective November 6 With Notes Pressing
The 29.93% fall at Adagio Medical Holdings (NASDAQ:ADGM), to about USD 0.0604, came a day after it announced a 1-for-30 reverse split, approved on October 23, 2026 and effective November 6, 2026. Published coverage indicates split-adjusted trading from November 9, 2026, while the reason for the split and any Nasdaq deficiency were not verified. The compliance question sits beside a financing problem. In a September 23, 2026 filing the company said its 13% senior secured convertible notes would convert at the lower of the existing price or 85% of the lowest five-day volume-weighted average price through October 31, 2026, which gives noteholders more shares per dollar as the stock falls. Preliminary cash was about USD 7.7 million at June 30, 2026, 25 of 43 full-time jobs were cut and the board is exploring strategic alternatives. Third quarter results are expected on November 11, 2026, per published coverage. Quoted moves at USD 1.66 million of market value can reverse.
Baird Medical Investment Holdings Limited (NASDAQ:BDMD): A Deficiency Notice and a Longer Runway to Cure
The 20.26% rise at Baird Medical Investment Holdings Limited (NASDAQ:BDMD), to USD 0.1312 on about 108.64 million shares, came a day after the company announced a Nasdaq letter dated November 2, 2026 under Listing Rule 5550(a)(2), because its bid had stayed below USD 1.00 for 30 consecutive business days. The notice has no immediate effect on trading. The company has 180 calendar days, until May 3, 2027, to close at or above USD 1.00 for ten consecutive business days, and a second 180-day period may be available if it meets other listing standards and gives written notice of its intent to cure. Management said it is looking into various options, and the notice did not mention a reverse split, which none has confirmed. A separate November 4, 2026 statement said the company knew of no undisclosed reason for the share price decline. At USD 0.1312, a cure without a split would need a gain of more than sevenfold, simple arithmetic on published numbers. With a market value near USD 4.2 million, quoted moves can reverse.
Where Things Stand
These five show that Listing Rules shape trading before any split takes effect, and the balance of evidence is cautious: a reverse split resets the quote but not the business, and the names here also carry dilution, funding or pivot risk. Ping An Biomedical Co., Ltd. (NASDAQ:PASW) and NewGenIvf have pending or repeated actions. CL Workshop Group Limited (NASDAQ:NWGL) uses an ADS ratio change. Adagio Medical has a convertible note formula. A bounce at Baird Medical does not cure the deficiency. Nothing here implies a continued fall or recovery. Next markers are the first post-change sessions, Nasdaq letters, the November 11, 2026 Adagio results and any compliance plan at Baird Medical Investment Holdings Limited (NASDAQ:BDMD).




Please wait processing your request...